|
Market Closed -
Nasdaq
20:00:00 28/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 3.540 USD | +4.73% |
|
+5.04% | -14.90% |
Evolution of the Average Target: Galectin Therapeutics Inc.
Evolution of the Target Price: Galectin Therapeutics Inc.
Changes in Analyst Recommendations: Galectin Therapeutics Inc.
94b3d76.ZlW5JCKuvmCiZe76VP_NAJWrLbuXQBkTqmYtpnZr2kU.U2bbdxKfhwGPH6-LGI6ucNviZ_39B0oq7x9BnkETnjwKHoBtZPnNJfgR3g~586d54e6f253b1d5e8d0e519d955672e
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | - | +210.73% | |||
| +41.72% | |||||
| +26.36% | |||||
| +10.61% | |||||
| +10.61% | |||||
| +16.9% | |||||
| +37.16% | |||||
| +42.61% | |||||
| -17.48% | |||||
| +30.19% | |||||
| Average | +40.94% | |||||
| Weighted average by Cap. | +22.88% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
3.540USD
Average target price
11.00USD
Spread / Average Target
+210.73%
High Price Target
11.00USD
Spread / Highest target
+210.73%
Low Price Target
11.00USD
Spread / Lowest Target
+210.73%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- GALT Stock
- Consensus Galectin Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
